万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://www.thelancet.com/journals/lanhae/home
https://www.journals.elsevier.com/the-lancet-haematology/
3、投稿网址：
https://www.editorialmanager.com/thelancethaematology
4、官网邮箱：haematology@lancet.com
5、期刊刊期：月刊，一年出版12期。
2021年5月27日星期四
投稿须知【官网信息】
Information for Authors
The Lancet Haematology is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice, including, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine. All original research judged eligible for consideration by the journal’s editors will be peer-reviewed within 72 h and, if accepted, published online within 8 weeks from submission. The journal will also publish relevant commentary and correspondence. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. We also welcome videos. Further details on the different sections of The Lancet Haematology, and how to submit to the journal, are provided below. If you require further clarification, the journal’s editorial staff will be pleased to help (email haematology@lancet.com).
Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE’s guidelines.
First submissions to The Lancet Haematology should include:
1 Covering letter
2 Manuscript including tables and panels
3 Figures
4 Author statement form (see next section)
5 Declaration of interests and source of funding statements (see next section)
6 In-press papers—one copy of each with acceptance letters
7 Protocols and CONSORT details for randomised controlled trials (see Articles)
8 We encourage disclosure of correspondence from other journals and reviewers, if previously submitted, and we might contact relevant editors of such journals
9 Research in context panel, for all primary research Articles
……
更多详情：
https://els-jbs-prod-cdn.jbs.elsevierhealth.com/pb/assets/raw/Lancet/authors/tlhaem-info-for-authors.pdf
